TCS-401 HCI is a novel, potent and selective inhibitor of protein-tyrosine phosphatase 1B (PTP1B) with Ki of 0.29 µM.

F1063-0967 is a novel inhibitor of dual-specificity phosphatase 26 (DUSP26), inducing apoptosis in IMR-32 cell line.

Sodium orthovanadate, an inorganic compound with chemical formula of Na3VO4, is a potent inhibitor for several enzymes such as protein tyrosine phosphatases (PTPs), alkaline phosphatase (ALP), and ATPase.

Idoxuridine (IdUrd; 5-Iodo-2′-deoxyuridine; 5-IUdR) is a potent anti-herpesvirus antiviral and anticancer drug.

BN-82002, formerly known as CDC25 Phosphatase Inhibitor I, is a cell-permeable ortho-hydroxybenzylamino compound that exhibits anti-tumor properties.

INVIVO-4823, formerly known as LMPTP inhibitor1; is a potent inhibitor of the low-molecular-weight tyrosine phosphatase (LMPTP).

3α-Aminocholestane (also known as 3AC) is a potent and selective SH2 domain-containing inositol-5′-phosphatase 1 (SHIP1) inhibitor with immunomodulatory and antitumor effects.

GSK-2830371 (GSK2830371) is a first-in-class, potent, orally bioactive and highly selective allosteric inhibitor of Wip1 (wild-type p53-induced phosphatas) phosphatase with potential anticancer activity.

SMAP-2 (DT-1154; SMAP 2; DT1154; SMAP2; DT 1154) is a novel, potent and orally bioavailable phosphatase 2A (PP2A) activator with potential anticancer activity. It inhibits the growth of KRAS-mutant lung cancers.

PTP1B-IN-1 is a potent and new class of inhibitor of protein tyrosine phosphatase-1B (PTP1B) with IC50 of 1.6 mM; It incorporates the 1,2,5-thiadiazolidin-3-one-1,1-dioxide template that was identified through structure-based design.